Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients
- PMID: 19620612
- PMCID: PMC2715575
- DOI: 10.1212/WNL.0b013e3181ae7cbc
Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients
Abstract
Background: Pathogenic mutations in rapsyn result in endplate acetylcholine receptor (AChR) deficiency and are a common cause of postsynaptic congenital myasthenic syndromes.
Methods: Clinical, electrophysiologic, pathologic, and molecular studies were done in 39 patients.
Results: In all but one patient, the disease presented in the first 2 years of life. In 9 patients, the myasthenic symptoms included constant or episodic ophthalmoparesis, and 1 patient had a pure limb-girdle phenotype. More than one-half of the patients experienced intermittent exacerbations. Long-term follow-up was available in 25 patients after start of cholinergic therapy: 21 became stable or were improved and 2 of these became asymptomatic; 3 had a progressive course; and 1 died in infancy. In 7 patients who had endplate studies, the average counts of AChR per endplate and the synaptic response to ACh were less reduced than in patients harboring low AChR expressor mutations. Eight patients were homozygous and 23 heterozygous for the common p.N88K mutation. Six mutations, comprising 3 missense mutations, an in-frame deletion, a splice-site mutation, and a nonsense mutation, are novel. Homozygosity for p.N88K was associated with varying grades of severity. No genotype-phenotype correlations were observed except in 8 Near-Eastern patients homozygous for the promoter mutation (c.-38A>G), who had a mild course.
Conclusions: All but 1 patient presented early in life and most responded to cholinergic agonists. With early diagnosis and therapy, rapsyn deficiency has a benign course in most patients. There was no consistent phenotype-genotype correlation except for an E-box mutation associated with jaw deformities.
Figures


Similar articles
-
Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering.Muscle Nerve. 2003 Sep;28(3):293-301. doi: 10.1002/mus.10433. Muscle Nerve. 2003. PMID: 12929188
-
Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.Am J Hum Genet. 2002 Apr;70(4):875-85. doi: 10.1086/339465. Epub 2002 Jan 14. Am J Hum Genet. 2002. PMID: 11791205 Free PMC article.
-
Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation.Neuromuscul Disord. 2004 Jan;14(1):24-32. doi: 10.1016/j.nmd.2003.07.002. Neuromuscul Disord. 2004. PMID: 14659409
-
[Congenital myasthenic syndromes due to mutations in the rapsyn gene].Rev Neurol (Paris). 2004 May;160(5 Pt 2):S78-84. doi: 10.1016/s0035-3787(04)71009-7. Rev Neurol (Paris). 2004. PMID: 15269664 Review. French.
-
Congenital myasthenic syndromes: progress over the past decade.Muscle Nerve. 2003 Jan;27(1):4-25. doi: 10.1002/mus.10269. Muscle Nerve. 2003. PMID: 12508290 Review.
Cited by
-
Diagnosis of muscle diseases presenting with early respiratory failure.J Neurol. 2015 May;262(5):1101-14. doi: 10.1007/s00415-014-7526-1. Epub 2014 Nov 7. J Neurol. 2015. PMID: 25377282 Review.
-
Congenital familial myasthenic syndromes: disease and course in an affected dizygotic twin pair.BMJ Case Rep. 2013 Jan 29;2013:bcr2012007651. doi: 10.1136/bcr-2012-007651. BMJ Case Rep. 2013. PMID: 23365176 Free PMC article.
-
Abnormal decrement on high-frequency repetitive nerve stimulation in congenital myasthenic syndrome with GFPT1 mutations and review of literature.Front Neurol. 2022 Sep 15;13:926786. doi: 10.3389/fneur.2022.926786. eCollection 2022. Front Neurol. 2022. PMID: 36188410 Free PMC article.
-
Membraneless condensates by Rapsn phase separation as a platform for neuromuscular junction formation.Neuron. 2021 Jun 16;109(12):1963-1978.e5. doi: 10.1016/j.neuron.2021.04.021. Epub 2021 May 24. Neuron. 2021. PMID: 34033754 Free PMC article.
-
Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.Lancet Neurol. 2015 Apr;14(4):420-34. doi: 10.1016/S1474-4422(14)70201-7. Lancet Neurol. 2015. PMID: 25792100 Free PMC article. Review.
References
-
- Maimone MM, Enigk RE. The intracellular domain of the nicotinic acetylcholine receptor alpha subunit mediates its coclustering with rapsyn. Mol Cell Neurosci 1999;14:340–354. - PubMed
-
- Ramarao MK, Bianchetta MJ, Lanken J, Cohen JB. Role of rapsyn tetratricopeptide repeat and coiled-coil domains in self-association and nicotinic acetylcholine receptor clustering. J Biol Chem 2001;276:7475–7483. - PubMed
-
- Antolik C, Catino DH, Resneck WG, Bloch RJ. The tetratricopeptide repeat domains of rapsyn bind directly to cytoplasmic sequences of the muscle-specific kinase. Neuroscience 2006;141:87–100. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical